Literature DB >> 14572297

Optimal treatment of vascular birthmarks.

Jochen A Werner1, Anja A Dünne, Burkard M Lippert, Benedikt J Folz.   

Abstract

Optimal functional and cosmetic outcomes for vascular lesions require a thorough preoperative diagnosis of vascular anomalies, since correct classification of each vascular lesion has a direct influence on the treatment of choice. Many different classification systems have been discussed controversially. Based on clinical practicality and significant accuracy of forecast with regard to the clinical course of a lesion, Mulliken and Glowacki's biologic classification gained most clinical relevance and has become accepted as the official classification scheme by the International Society for the Study of Vascular Anomalies (ISSVA). Based on comprehensive description of relevant literature results, the current communication shall give an overview of differing, internationally accepted treatments. Although conservative management can be proposed for uncomplicated hemangiomas occurring in infancy, the proliferative progression of these lesions provides an adequate indication for treatment, while vascular malformations, which usually persist throughout life, always require therapeutic intervention if they start to cause clinical symptoms. Based on individual parameters (such as diameter, location and growth dynamics), different treatments, including cryotherapy, corticosteroids, laser therapy, sclerotherapy, surgery, and/or embolization, can be performed successfully. Currently, however, none of these treatments represents the solitary treatment of choice.

Entities:  

Mesh:

Year:  2003        PMID: 14572297     DOI: 10.2165/00128071-200304110-00003

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  3 in total

1.  Treatment with propranolol for infantile hemangiomas: A case series of 106 infants.

Authors:  Shang-Bin Li; Guang-Qi Xu; Feng Gao; Ran Huo
Journal:  Exp Ther Med       Date:  2015-05-08       Impact factor: 2.447

Review 2.  Propranolol is an effective treatment for airway haemangiomas: a critical analysis and meta-analysis of published interventional studies.

Authors:  P V Vlastarakos; G X Papacharalampous; M Chrysostomou; E-F Tavoulari; A Delidis; D Protopapas; T P Nikolopoulos
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-08       Impact factor: 2.124

3.  Propranolol therapy of infantile hemangiomas: efficacy, adverse effects, and recurrence.

Authors:  Qiang Xiao; Qin Li; Bin Zhang; Wenlin Yu
Journal:  Pediatr Surg Int       Date:  2013-03-22       Impact factor: 1.827

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.